What Nurse Practitioners Should Know About Direct‐to‐Consumer Advertising of Prescription Medications
- 1 July 2003
- journal article
- review article
- Published by Wiley in Journal of the American Academy of Nurse Practitioners
- Vol. 15 (7) , 297-304
- https://doi.org/10.1111/j.1745-7599.2003.tb01312.x
Abstract
To describe the marketing strategies of direct-to-consumer (DTC) advertising and the risks, benefits, and potential influence on the prescribing practices of nurse practitioners (NPs). Journal articles, media sources, and clinical experience. The effect of DTC advertising of prescription medications on NPs has not been well studied. Although there are studies that examine the effects of DTC advertising on physician prescribing as well as the effects of this practice on the consumer, opinions on the benefits of DTC advertising are varied. NPs need to recognize the potential influence of DTC advertising and to be prepared to guide patients toward appropriate medication choices by participating in a partnership with patients. Health care providers, including NPs, need to work with the pharmaceutical industry to encourage accountability of DTC advertising, thus improving dissemination of correct information and promoting positive outcomes for health consumers and patients.Keywords
This publication has 21 references indexed in Scilit:
- Promotion of Prescription Drugs to ConsumersNew England Journal of Medicine, 2002
- Relationship between direct-to-consumer advertising and physician diagnosing and prescribingAmerican Journal of Health-System Pharmacy, 2002
- Direct-to-consumer advertisements for prescription drugs: what are Americans being sold?The Lancet, 2001
- Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotionsThe American Journal of Medicine, 2001
- Direct-to-Consumer Promotion of Prescription DrugsPharmacoEconomics, 2001
- The Rise of Direct-to-Consumer Advertising of Prescription Drugs in the United StatesJAMA, 2000
- Gifts to Physicians in the Consumer Marketing EraJAMA, 2000
- COX-1–Sparing NSAIDs—Is the Enthusiasm Justified?Published by American Medical Association (AMA) ,1999
- Doctors feel pressurised by direct to consumer advertisingBMJ, 1999
- The past, present, and future of direct-to-consumer prescription drug advertisingClinical Therapeutics, 1999